This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Innovation Ulster Limited, University of Ulster. Active years: 2022-2026.
Location History:
- Ballycastle Antrim, GB (2022)
- Newtownabbey Antrim, GB (2024)
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Inventor Anthony Mchale
Introduction
Anthony Mchale is a notable inventor based in Ballycastle, Antrim, GB. He has made significant contributions to the field of medical technology, particularly in cancer treatment. With a total of two patents to his name, Mchale's work focuses on innovative therapies that enhance the effectiveness of existing cancer treatments.
Latest Patents
Mchale's latest patents include advancements in sonodynamic therapy and the use of calcium peroxide nanoparticles as adjuvant therapy. The first patent relates to microbubble complexes designed for sonodynamic therapy. These complexes consist of microbubbles associated with linking groups that are bound to sonosensitising and chemotherapeutic agents. This invention is particularly effective for treating deep-sited tumors, such as pancreatic cancer. The second patent involves calcium peroxide nanoparticles with a pH-responsive coating, aimed at enhancing therapies for hypoxic tumor cells. These nanoparticles are especially useful in therapies that rely on oxygen, including photodynamic therapy, sonodynamic therapy, and radiotherapy.
Career Highlights
Mchale is affiliated with the University of Ulster, where he continues to develop his innovative ideas and contribute to research in cancer therapies. His work has the potential to significantly impact the treatment landscape for various types of cancer.
Collaborations
Mchale collaborates with esteemed colleagues, including John Francis Callan and Sukanta Kamila, to further advance his research and innovations in the field.
Conclusion
Anthony Mchale's contributions to medical technology through his patents demonstrate his commitment to improving cancer treatment methodologies. His innovative approaches have the potential to change the lives of many patients facing challenging diagnoses.